RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Brandon Capital
B

Brandon Capital portfolio

Brandon Capital has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 5.
Deals, last 12 months: 1.
Rounds led: 2 of 7.
Capital in their rounds: $785M.
Latest deal: AdvanCell · Jul 15, 2026.
About this page

It is a venture capital firm based in Melbourne, AU, founded in 2006. It led 2 of the 7 rounds it joined. Its most recent investment on record is AdvanCell's $315M Series B+ round in July 2026, alongside Fidelity Management & Research Company, Morningside, Eli Lilly and 15 others. By category, its portfolio leans toward Health and bio (5) and Manufacturing and industrial (1). It has co-invested with Abingworth, Tenmile and Eli Lilly, most often Abingworth (3 rounds).

About Brandon Capital

Firm type: Venture capital.
Headquarters: Melbourne, AU.
Founded: 2006.
Stages: Series A.
Sectors: Biotech, Digital Health, Medical Devices.
Portfolio companies: 14.
Exits: 1.
Rounds led: 0.

Funds raised

FundFund #SizeAnnounced
BBrandon Capital-$430M
BioMelbourne Network
BBrandon Capital-$290M
Fierce Biotech

What Brandon Capital invests in

Brandon Capital recent investments

CompanyRoundDateAlongside
AAdvanCellSeries B+ · $315MFidelity Management & Research Company, Morningside, Eli Lilly +15
AAdvanCellSeries B+ · $112MMorningside, Abingworth (lead), SymBiosis (lead) +3
CCatalYmSeries B+ · $150MGilde Healthcare, Forbion Capital Partners, Novartis Venture Fund +5
MMyricx BioSeries A · $120MCancer Research Horizons, Novo Holdings (lead), Eli Lilly +3
AAravaxSeries B+ · $20M · leadTenmile (lead)
CCatalYmSeries B+ · $50M · leadForbion Capital Partners, Novartis Venture Fund, Bayern Kapital +4
NNRG TherapeuticsSeries A · $18MOmega Funds (lead), Parkinson's Virtual Biotech

How Brandon Capital invests

StageDealsCapital in rounds
Series B+ 5 71%$647M
Series A 2 29%$138M
YearDealsCapital in rounds
2022 3 43%$88M
2024 2 29%$270M
2025 1 14%$112M
2026 1 14%$315M

Brandon Capital portfolio companies

CompanyRound with Brandon CapitalTotal raisedLatest raise
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
CCatalYm
Health and bio
Series B+ · $150M$259.04MJul 16, 2024
Series B+
MMyricx Bio
Health and bio
Series A · $120M$120MJul 8, 2024
Series A
AAravax
Health and bio
Series B+ · $20M · lead$62MJan 23, 2024
Series B+
NNRG Therapeutics
Health and bio
Series A · $18M$85MSep 8, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Brandon Capital raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 7 rounds on Recent Funding that name Brandon Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Brandon Capital, which is a subset of its real portfolio. API: /api/v1/investors/brandon-capital (get a free API key). More: the most active VC firms and new venture capital funds.